Fixed Price IPO | ₹10 Cr | Listed at BSE SME | Thu, Mar 17, 2022 - Tue, Mar 22, 2022
Evoq Remedies IPO is a fixed price issue of ₹9.72 crores. The issue is entirely a fresh issue of 0.36 crore shares of ₹9.72 crore.
Evoq Remedies IPO bidding started from Mar 17, 2022 and ended on Mar 22, 2022. The allotment for Evoq Remedies IPO was finalized on Mar 25, 2022. The shares got listed on BSE SME on Mar 30, 2022.
Evoq Remedies IPO price is ₹27 per share. The lot size for an application is 4,000. The minimum amount of investment required by an individual investor (retail) is ₹1,08,000 (4000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (8,000 shares), amounting to ₹2,16,000.
Swastika Investmart Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Sunflower Broking Pvt.Ltd..
Refer to Evoq Remedies IPO RHP for detailed Information.
IPO Open
Thu, Mar 17, 2022
IPO Close
Tue, Mar 22, 2022
Issue Price
₹27 per share
Market Cap (Pre-IPO)
₹36.72 Cr
| IPO Date | 17 to 22 Mar, 2022 |
| Listed on | Wed, Mar 30, 2022 |
| Face Value | ₹10 per share |
| Issue Price | ₹27 per share |
| Lot Size | 4,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Total Issue Size | 36,00,000 shares (agg. up to ₹10 Cr) |
| Reserved for Market Maker | 1,80,000 shares Sunflower Broking Pvt.Ltd. (agg. up to ₹0.4860 Cr) |
| Fresh Issue (Ex Market Maker) | 34,20,000 shares (agg. up to ₹9 Cr) |
| Net Offered to Public | 34,20,000 shares (agg. up to ₹9 Cr) |
| Share Holding Pre Issue | 1,00,00,000 shares |
| Share Holding Post Issue | 1,36,00,000 shares |
| BSE Script Code | 543500 |
| ISIN | INE0JVD01011 |
Evoq Remedies IPO comprises a total issue size of 36,00,000 shares. The net offer to the public is 34,20,000 shares, after excluding 1,80,000 shares allotted on a firm basis. Of the Net offer 17,10,000 (50.00%) allocated to NII 17,10,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 17,10,000 | 50.00% | 47.50% |
| Retail Shares Offered | 17,10,000 | 50.00% | 47.50% |
| Firm Reservations | |||
| Market Maker Shares Offered | 1,80,000 | 5.00% | |
| Total Shares Offered | 36,00,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 4,000 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4,000 | ₹1,08,000 |
| Retail (Max) | 1 | 4,000 | ₹1,08,000 |
| HNI (Min) | 2 | 8,000 | ₹2,16,000 |
Incorporated in 2010, EVOQ Remedies Limited specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices. The company procures all the products from WHO-GMP certified & reliable Manufacturers & Importers, who follow procedures as per the stringent national and international quality and safety standards.
Competitive strengths:
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To Meet Incremental Working Capital Requirements | 6.44 |
| 2 | General Corporate Purpose | 2.33 |
| KPI | |
|---|---|
| RoNW | 96.94% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 10.05 | |
| P/E (x) | 33.75 | |
| Promoter Holding | 99.99% | 73.53% |
| Market Cap | ₹36.72 Cr. |
The Evoq Remedies IPO is subscribed 1.67 times on March 22, 2022 6:48:00 PM (Day 3). The public issue subscribed 3.03 times in the retail category, [.] times in the QIB category, and 0.3 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| NII* | 0.3 | 17,10,000 | 5,20,000 |
| Retail | 3.03 | 17,10,000 | 51,76,000 |
| Total | 1.67 | 34,20,000 | 56,96,000 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Lead Manger Fees including Underwriting Commission | 0.18 |
| 2 | Fees for Advisor to the Issue | 0.03 |
| 3 | Fees Payable to Registrar to the Issue | 0.01 |
| 4 | Fees Payable Advertising, Marketing Expenses and Printing Expenses | 0.64 |
| 5 | Fees Payable to Regulators including Stock Exchanges and other Intermediaries | 0.04 |
| 6 | Fees payable to Peer Review Auditor | 0.01 |
| 7 | Fees Payable to Market Maker (for Two Years) | 0.04 |
| 8 | Escrow Bank Fees | 0.01 |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹27.00 |
| Open | ₹25.00 |
| Low | ₹23.75 |
| High | ₹25.00 |
| Last Trade | ₹23.75 |
Lead Manager Reports
Evoq Remedies IPO is a SME IPO of 36,00,000 equity shares of the face value of ₹10 aggregating up to ₹10 Crores. The issue is priced at ₹27 per share. The minimum order quantity is 4000.
The IPO opens on Thu, Mar 17, 2022, and closes on Tue, Mar 22, 2022.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Evoq Remedies IPO using UPI as a payment gateway. Zerodha customers can apply in Evoq Remedies IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Evoq Remedies IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Evoq Remedies IPO opens on Thu, Mar 17, 2022 and closes on Tue, Mar 22, 2022.
Evoq Remedies IPO lot size is 4000, and the minimum amount required for application is ₹1,08,000.
You can apply in Evoq Remedies IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Evoq Remedies IPO will be done on Friday, March 25, 2022, and the allotted shares will be credited to your demat account by Tue, Mar 29, 2022. Check the Evoq Remedies IPO allotment status.
The Evoq Remedies IPO listing date is on Wed, Mar 30, 2022.
